12 August 2013Asia
IPAB revokes Allergan eye drug patent
On August 8 the Indian Intellectual Property Appellate Board (IPAB) revoked another patent owned by a Western pharmaceutical company – this time related to Allergan’s eye drug Combigan.
On August 8 the Indian Intellectual Property Appellate Board (IPAB) revoked another patent owned by a Western pharmaceutical company – this time related to Allergan’s eye drug Combigan.
